Literature DB >> 18250571

MicroPET detection of regional brain activation induced by colonic distention in a rat model of visceral hypersensitivity.

Katsuyo Ohashi1, Katsuomi Ichikawa, Laigao Chen, Michael Callahan, Kenneth Zasadny, Yoichi Kurebayashi.   

Abstract

Using microPET and (18)F-fluorodeoxyglucose ((18)F-FDG) as a tracer, we investigated regional brain activation in a rat model of visceral hypersensitivity induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS). TNBS injection into the proximal colon through laparotomy resulted in a significant, sustained decrease in the pain threshold to mechanical distention of the distal colon, indicating a phenomenon referred to as visceral hypersensitivity. When TNBS-induced colonic hypersensitivity was fully developed, all the TNBS-treated rats presented characteristic pain behaviors in response to colonic distention at previously innocuous pressure (0-35 mmHg) that produced no abdominal pain in sham-operated control animals. In microPET study, colonic distention at the normally non-painful pressure produced significant increases in (18)F-FDG uptake in the thalamus and sensory cortex I of TNBS-treated rats. Since the increases in (18)F-FDG uptake in the brain regions were completely abolished by an analgesic dose of morphine (375 microg/kg, s.c.), it is most likely that the regional brain activation detected by microPET is a pain-related central event. The pharmacological and microPET data indicate that colonic distention at the normally non-painful pressure activates specific brain regions in rats with TNBS-induced visceral hypersensitivity, and the microPET protocol described here could provide an objective measure to test visceral analgesic compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250571     DOI: 10.1292/jvms.70.43

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  6 in total

Review 1.  The role of experimental models in developing new treatments for irritable bowel syndrome.

Authors:  Daniel P Holschneider; Sylvie Bradesi; Emeran A Mayer
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 3.869

Review 2.  Studying the brain-gut axis with pharmacological imaging.

Authors:  Kirsten Tillisch; Zhuo Wang; Lisa Kilpatrick; Daniel P Holschneider; Emeran A Mayer
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

3.  Gabapentin reverses central hypersensitivity and suppresses medial prefrontal cortical glucose metabolism in rats with neuropathic pain.

Authors:  Hsiao-Chun Lin; Yu-Hsin Huang; Tzu-Hao Harry Chao; Wen-Ying Lin; Wei-Zen Sun; Chen-Tung Yen
Journal:  Mol Pain       Date:  2014-09-25       Impact factor: 3.395

4.  Functional MRI of the Reserpine-Induced Putative Rat Model of Fibromyalgia Reveals Discriminatory Patterns of Functional Augmentation to Acute Nociceptive Stimuli.

Authors:  Jack A Wells; Sayaka Shibata; Akihiko Fujikawa; Masayasu Takahashi; Tsuneo Saga; Ichio Aoki
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

5.  Neural correlates of hyperalgesia in the monosodium iodoacetate model of osteoarthritis pain.

Authors:  Maryam Abaei; Devi R Sagar; Elizabeth G Stockley; Clare H Spicer; Malcolm Prior; Victoria Chapman; Dorothee P Auer
Journal:  Mol Pain       Date:  2016-04-11       Impact factor: 3.395

6.  Estrogen-dependent visceral hypersensitivity following stress in rats: An fMRI study.

Authors:  Catherine S Hubbard; Jane M Karpowicz; Andrew J Furman; Joyce Teixeira da Silva; David A Seminowicz; Richard J Traub
Journal:  Mol Pain       Date:  2016-06-17       Impact factor: 3.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.